Eduardo Mascareno
MedHexim1
Affiliations
State University of New York
Technologies
Diagnostic
Therapeutic
Indication
Drug Discovery
Metabolic Disease
Obesity
Executive Summary
View/DownloadWebsite
www.medheximllc.comMedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer.